Michael H Malim Selected Research

Tumor Necrosis Factor Inhibitors

1/2022	Humoral and cellular immunogenicity to a second dose of COVID-19 vaccine BNT162b2 in people receiving methotrexate or targeted immunosuppression: a longitudinal cohort study.
9/2021	The effect of methotrexate and targeted immunosuppression on humoral and cellular immune responses to the COVID-19 vaccine BNT162b2: a cohort study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michael H Malim Research Topics

Disease

43	Infections 09/2023 - 08/2002
16	COVID-19 09/2023 - 12/2020
6	Neoplasms (Cancer) 01/2022 - 01/2019
6	Virus Diseases (Viral Diseases) 11/2021 - 08/2002
3	Breakthrough Infections 09/2023 - 01/2022
3	Acquired Immunodeficiency Syndrome (AIDS) 07/2015 - 08/2002
2	Severe Acute Respiratory Syndrome 01/2023 - 01/2021
2	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2022 - 09/2021
2	Necrosis 01/2022 - 09/2021
2	HIV Infections (HIV Infection) 08/2015 - 11/2006
1	Fatigue 05/2023
1	Post-Acute COVID-19 Syndrome 05/2023
1	Type 2 Diabetes Mellitus (MODY) 01/2022
1	Obesity 01/2022
1	Type I Syndactyly 01/2022
1	Pulmonary Embolism 01/2021
1	Reinfection 12/2020
1	Lymphopenia (Lymphocytopenia) 11/2020
1	Inflammation (Inflammations) 07/2015
1	Disease Progression 07/2015
1	Measles 03/2012
1	Mumps 03/2012

Drug/Important Bio-Agent (IBA)

20	Proteins (Proteins, Gene)FDA Link 01/2023 - 08/2002
8	VaccinesIBA 09/2023 - 12/2020
8	Antiviral Agents (Antivirals)IBA 01/2022 - 09/2009
8	CytidineIBA 01/2019 - 04/2005
8	Complementary DNA (cDNA)IBA 01/2018 - 11/2003
7	InterferonsIBA 11/2020 - 10/2013
6	BNT162 VaccineIBA 09/2023 - 01/2021
5	Neutralizing AntibodiesIBA 09/2023 - 12/2020
5	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 06/2003
5	vif Gene ProductsIBA 11/2006 - 08/2002
4	COVID-19 VaccinesIBA 09/2023 - 01/2021
4	Immunoglobulin G (IgG)IBA 01/2022 - 12/2020
4	RNA (Ribonucleic Acid)IBA 01/2021 - 11/2006
4	Interferon Type IIBA 01/2019 - 02/2013
3	AntibodiesIBA 01/2023 - 01/2021
3	APOBEC-1 DeaminaseIBA 12/2011 - 11/2003
2	N-(2-cyanoethylene)urea (BA 1)IBA 09/2023 - 10/2022
2	Interleukin-6 (Interleukin 6)IBA 05/2023 - 11/2020
2	InterleukinsIBA 01/2022 - 09/2021
2	EpitopesIBA 01/2022 - 01/2022
2	Broadly Neutralizing AntibodiesIBA 01/2022 - 06/2021
2	Tumor Necrosis Factor InhibitorsIBA 01/2022 - 09/2021
2	Viral DNAIBA 01/2022 - 03/2004
2	Viral RNAIBA 01/2022 - 01/2022
2	Methotrexate (Mexate)FDA LinkGeneric 01/2022 - 09/2021
2	Interleukin-17 (Interleukin 17)IBA 01/2022 - 11/2020
2	mRNA VaccinesIBA 12/2021 - 01/2021
2	Messenger RNA (mRNA)IBA 11/2021 - 11/2006
2	Retroelements (Retrotransposon)IBA 06/2012 - 06/2008
2	Peptides (Polypeptides)IBA 12/2011 - 06/2008
2	Interferon-alpha (Interferon Alfa)IBA 12/2011 - 09/2010
2	PolynucleotidesIBA 03/2009 - 11/2006
2	Viral ProteinsIBA 03/2009 - 11/2006
1	Monoclonal AntibodiesIBA 09/2023
1	Amyloidogenic ProteinsIBA 01/2023
1	Amyloid (Amyloid Fibrils)IBA 01/2023
1	ApolipoproteinsIBA 01/2023
1	Glycoproteins (Glycoprotein)IBA 01/2023
1	Lipoproteins (Lipoprotein)IBA 01/2023
1	HDL LipoproteinsIBA 01/2023
1	Apolipoproteins D (Apo D)IBA 01/2023
1	N-methyl-valyl-amiclenomycin (BA 2)IBA 10/2022
1	Insulin (Novolin)FDA Link 01/2022
1	Interleukin-23 (Interleukin 23)IBA 01/2022
1	ruxolitinibIBA 01/2022
1	Indicators and Reagents (Reagents)IBA 01/2022
1	Immune Sera (Antisera)IBA 01/2022
1	Immunoglobulin M (IgM)IBA 01/2022
1	FurinIBA 11/2021
1	Peptide Hydrolases (Proteases)FDA Link 11/2021
1	Niclosamide FDA Link 01/2021
1	AntigensIBA 01/2021
1	Tyrosine Kinase InhibitorsIBA 01/2021
1	Immunoglobulins (Immunoglobulin)IBA 12/2020
1	Immunoglobulin A (IgA)IBA 12/2020
1	Interleukin-8 (Interleukin 8)IBA 11/2020
1	Interleukin-10 (Interleukin 10)IBA 11/2020
1	Small Interfering RNA (siRNA)IBA 01/2019
1	MutagensIBA 01/2019
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2019
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2019
1	Protein Isoforms (Isoforms)IBA 01/2019
1	Antiviral Restriction FactorsIBA 01/2018
1	UridineIBA 01/2018
1	CytokinesIBA 01/2016
1	Capsid Proteins (Capsid Protein)IBA 01/2016
1	Protein SIBA 08/2015
1	Biomarkers (Surrogate Marker)IBA 07/2015
1	human MX1 proteinIBA 08/2014
1	human MX2 proteinIBA 08/2014
1	triphosphoric acid (triphosphate)IBA 04/2014
1	HydrolasesIBA 04/2014
1	Nuclear Proteins (Protein, Nuclear)IBA 04/2014
1	Dynamins (Dynamin)IBA 10/2013
1	gag Gene Products (gag Protein)IBA 10/2013
1	human APOBEC3 proteinsIBA 09/2008
1	Tryptophan (L-Tryptophan)FDA Link 04/2007

Therapy/Procedure

6	Therapeutics 01/2022 - 08/2002